Agilent Technologies, Inc. (A)
NYSE: A · Real-Time Price · USD
119.17
-0.25 (-0.21%)
At close: Jun 27, 2025, 4:00 PM
119.17
0.00 (0.00%)
After-hours: Jun 27, 2025, 5:12 PM EDT
Agilent Technologies Revenue
Agilent Technologies had revenue of $1.67B in the quarter ending April 30, 2025, with 6.04% growth. This brings the company's revenue in the last twelve months to $6.63B, up 0.56% year-over-year. In the fiscal year ending October 31, 2024, Agilent Technologies had annual revenue of $6.51B, down -4.73%.
Revenue (ttm)
$6.63B
Revenue Growth
+0.56%
P/S Ratio
5.15
Revenue / Employee
$370,279
Employees
17,900
Market Cap
33.85B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Oct 31, 2024 | 6.51B | -323.00M | -4.73% |
Oct 31, 2023 | 6.83B | -15.00M | -0.22% |
Oct 31, 2022 | 6.85B | 529.00M | 8.37% |
Oct 31, 2021 | 6.32B | 980.00M | 18.36% |
Oct 31, 2020 | 5.34B | 176.00M | 3.41% |
Oct 31, 2019 | Pro | Pro | Pro |
Oct 31, 2018 | Pro | Pro | Pro |
Oct 31, 2017 | Pro | Pro | Pro |
Oct 31, 2016 | Pro | Pro | Pro |
Oct 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
A News
- 15 days ago - Agilent to Showcase New Products and Innovations at HPLC 2025 - Business Wire
- 23 days ago - Agilent Technologies, Inc. (A) Jefferies Global Healthcare Conference - (Transcript) - Seeking Alpha
- 4 weeks ago - Agilent Technologies, Inc. (A) Q2 2025 Earnings Conference Call Transcript - Seeking Alpha
- 4 weeks ago - Life sciences firm Agilent beats quarterly estimates on instrument demand - Reuters
- 4 weeks ago - Agilent Reports Second-Quarter Fiscal Year 2025 Financial Results - Business Wire
- 4 weeks ago - Agilent Names August Specht as Chief Technology Officer - Business Wire
- 4 weeks ago - Agilent Announces the Enhanced 8850 Gas Chromatograph: Compact, Powerful, and Now Mass Spec-Connected for Superior Analytical Performance - Business Wire
- 4 weeks ago - Agilent Unveils the Next Generation in LC-Mass Detection: The InfinityLab Pro iQ Series - Business Wire